Therapy for Rare Bone Disorder Shows Promise in NIH Clinical Trial

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

04/04/2023 03:15 PM EDT

Medication is the first to reduce bone-weakening process in patients with fibrous dysplasia.